Literature DB >> 2599056

Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.

E Kapaki1, J Segditsa, C Zournas, D Xenos, C Papageorgiou.   

Abstract

In a total of 62 samples of cerebrospinal fluid (CSF) and an equal number of serum samples obtained from 16 patients suffering from amyotrophic lateral sclerosis, 22 patients suffering from miscellaneous neurological diseases, and 24 controls, lead was measured by atomic absorption spectrophotometry. No statistical difference in lead concentration was found between the above three groups.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2599056     DOI： 10.1007/bf01950171

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  4 in total

1.  Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis.

Authors:  T Stober; W Stelte; K Kunze
Journal:  J Neurol Sci       Date:  1983-09       Impact factor: 3.181

2.  Serum protein binding of lead in vitro in amyotrophic lateral sclerosis patients and controls.

Authors:  S Conradi; L O Ronnevi; H Stibler
Journal:  J Neurol Sci       Date:  1978-06       Impact factor: 3.181

3.  Further studies on the erythrocyte uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controls. Abnormal erythrocyte fragility in ALS.

Authors:  L O Ronnevi; S Conradi; G Nise
Journal:  J Neurol Sci       Date:  1982 Nov-Dec       Impact factor: 3.181

4.  Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease.

Authors:  A O House; R J Abbott; D L Davidson; I T Ferguson; J A Lenman
Journal:  Br Med J       Date:  1978-12-16
  4 in total
  6 in total

1.  Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease.

Authors:  Serena Bucossi; Stefania Mariani; Mariacarla Ventriglia; Renato Polimanti; Massimo Gennarelli; Cristian Bonvicini; Patrizio Pasqualetti; Federica Scrascia; Simone Migliore; Fabrizio Vernieri; Paolo M Rossini; Rosanna Squitti
Journal:  Int J Alzheimers Dis       Date:  2011-06-15

Review 2.  Neurodegenerative diseases: an overview of environmental risk factors.

Authors:  Rebecca C Brown; Alan H Lockwood; Babasaheb R Sonawane
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

Review 3.  Understanding the human health effects of chemical mixtures.

Authors:  David O Carpenter; Kathleen Arcaro; David C Spink
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

Review 4.  A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis.

Authors:  Ming-Dong Wang; James Gomes; Neil R Cashman; Julian Little; Daniel Krewski
Journal:  J Occup Environ Med       Date:  2014-12       Impact factor: 2.162

Review 5.  Human tissue lead (Pb) levels and amyotrophic lateral sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Cristiano Farace; Giovanni Fiorito; Giuliana Solinas; Roberto Madeddu; Andrea Pisano; Federica Etzi; Angela Sabalic; Grazia Fenu; Yolande Asara
Journal:  Neurol Sci       Date:  2022-07-09       Impact factor: 3.830

6.  Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan.

Authors:  Yu Yu; Feng-Chiao Su; Brian C Callaghan; Stephen A Goutman; Stuart A Batterman; Eva L Feldman
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.